| # | Drug | Count |
|---|---|---|
| 0 | CLARITHROMYCIN | 11 |
| 1 | PREDNISOLONE | 8 |
| 2 | PREDNISOLONE ORAL | 8 |
| 3 | PREDNISOLONE ORAL SOLUTION | 8 |
| 4 | SULFAMETHOXAZOLE AND TRIMETHOPRIM | 6 |
| 5 | MONTELUKAST | 5 |
| 6 | MYCOPHENOLATE MOFETIL | 5 |
| 7 | TACROLIMUS | 5 |
| 8 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 5 |
| 9 | TACROLIMUS OINTMENT 0.1% | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRIPTORELIN | 2 | 0.0006 |
| 1 | CLARITHROMYCIN | 11 | 0.0003 |
| 2 | LEVALBUTEROL HYDROCHLORIDE | 1 | 0.0003 |
| 3 | HYDROCORTISONE SODIUM SUCCINATE | 1 | 0.0003 |
| 4 | ERYTHROMYCIN | 4 | 0.0002 |
| 5 | TOBRAMYCIN SOLUTION | 2 | 0.0002 |
| 6 | THEOPHYLLINE ANHYDROUS | 2 | 0.0002 |
| 7 | TOBRAMYCIN SULFATE | 2 | 0.0002 |
| 8 | RAMUCIRUMAB | 1 | 0.0002 |
| 9 | TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Macrolide Antimicrobial [EPC] | 12 | 0.0002 |
| 1 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 2 | Thymic Stromal Lymphopoietin Blocker [EPC] | 1 | 0.0001 |
| 3 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 3 | 0.0001 |
| 4 | Aminoglycoside Antibacterial [EPC] | 4 | 0.0001 |
| 5 | Antimycobacterial [EPC] | 2 | 0.0001 |
| 6 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 8 | 0.0001 |
| 7 | Dihydrofolate Reductase Inhibitor Antibacterial [EPC] | 6 | 0.0001 |
| 8 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 1 | 0.0001 |
| 9 | Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |